Abstract
Nanomedicine is an emerging field that integrates nanotechnology, biomolecular engineering, life sciences and medicine; it is expected to produce major breakthroughs in medical diagnostics and therapeutics. Due to the size-compatibility of nano-scale structures and devices with proteins and nucleic acids, the design, synthesis and application of nanoprobes, nanocarriers and nanomachines provide unprecedented opportunities for achieving a better control of biological processes, and drastic improvements in disease detection, therapy, and prevention. Recent advances in nanomedicine include the development of functional nanoparticle based molecular imaging probes, nano-structured materials as drug/gene carriers for in vivo delivery, and engineered molecular machines for treating single-gene disorders. This review focuses on the development of molecular imaging probes and engineered nucleases for nanomedicine, including quantum dot bioconjugates, quantum dot-fluorescent protein FRET probes, molecular beacons, magnetic and gold nanoparticle based imaging contrast agents, and the design and validation of zinc finger nucleases (ZFNs) and TAL effector nucleases (TALENs) for gene targeting. The challenges in translating nanomedicine approaches to clinical applications are discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Wgner V, Dullaart A, Bock A K, et al. The emerging nanomedicine landscape. Nat Biotechnol, 2006, 24: 1211–1217
Nie S M, Yun X, Gloria J K, et al. Nanotechnology Applications in Cancer. Ann Rev Biomed Eng, 2007, 9: 257–288
Kim B Y, Rutka J T, Chan W C. Nanomedicine. N Engl J Med, 2010, 363: 2434–2443
Smith A M, Gao X, Nie S. Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem Photobiol, 2004, 80: 377–385
Nitin N, Santangelo P J, Kim G, et al. Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. Nucleic Acids Res, 2004, 32: e58
Nie S, Emory S R. Probing single molecules and single nanoparticles by surface-enhanced raman scattering. Science, 1997, 275: 1102–1106
Chan W C, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science, 1998, 281: 2016–2018
Emory S R, Haskins W E, Nie S. Direct observation of size-dependent optical enhancement in single metal nanoparticles. J Am Chem Soc, 1998, 120: 8009–8010
Han M, Gao X, Su J Z, et al. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat Biotechnol, 2001, 19: 631–635
Chan W C, Maxwell D J, Gao X, et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol, 2002, 13: 40–46
Gao X, Chan W C, Nie S. Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. J Biomed Opt, 2002, 7: 532–537
Bailey R E, Nie S. Alloyed semiconductor quantum dots: tuning the optical properties without changing the particle size. J Am Chem Soc, 2003, 125: 7100–7106
Gao X, Cui Y, Levenson R M, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 2004, 22: 969–976
Lidke D S, Nagy P, Heintzmann R, et al. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol, 2004, 22: 198–203
Bruchez M, Moronne M, Gin P, et al. Semiconductor nanocrystals as fluorescent biological labels. Science, 1998, 281: 2013–2016
Akerman M E, Chan W C, Laakkonen P, et al. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA, 2002, 99: 12617–12621
Dubertret B, Skourides P, Norris D J, et al. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science, 2002, 298: 1759–1762
Wu X, Liu H, Liu J, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol, 2003, 21: 41–46
Jaiswal J K, Mattoussi H, Mauro J M, et al. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol, 2003, 21: 47–51
Larson D R, Zipfel W R, Williams R M, et al. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science, 2003, 300: 1434–1436
Ishii D, Kinbara K, Ishida Y, et al. Chaperonin-mediated stabilization and ATP-triggered release of semiconductor nanoparticles. Nature, 2003, 423: 628–632
Medintz I L, Clapp A R, Mattoussi H, et al. Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat Mater, 2003, 2: 630–638
Dahan M, Levi S, Luccardini C, et al. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science, 2003, 302: 442–445
Voura E B, Jaiswal J K, Mattoussi H, et al. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med, 2004, 10: 993–998
Garon E B, Marcu L, Luong Q, et al. Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells. Leuk Res, 2007, 31: 643–651
Hama Y, Koyama Y, Urano Y, et al. Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res Treat, 2007, 103: 23–28
Chattopadhyay P K, Price D A, Harper T F, et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med, 2006, 12: 972–977
Howarth M, Takao K, Hayashi Y, et al. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc Natl Acad Sci USA, 2005, 102: 7583–7588
Bonasio R, Carman C V, Kim E, et al. Specific and covalent labeling of a membrane protein with organic fluorochromes and quantum dots. Proc Natl Acad Sci USA, 2007, 104: 14753–14758
Chang E, Miller J S, Sun J, et al. Protease-activated quantum dot probes. Biochem Biophys Res Commun, 2005, 334: 1317–1321
Xu C, Xing B, Rao J. A self-assembled quantum dot probe for detecting beta-lactamase activity. Biochem Biophys Res Commun, 2006, 344: 931–935
Clapp A R, Medintz I L, Uyeda H T, et al. Quantum dot-based multiplexed fluorescence resonance energy transfer. J Am Chem Soc, 2005, 127: 18212–18221
Yao H, Zhang Y, Xiao F, et al. Quantum dot/bioluminescence resonance energy transfer based highly sensitive detection of proteases. Angew Chem Int Ed, 2007, 46: 4346–4349
Medintz I L, Clapp A R, Brunel F M, et al. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates. Nat Mater, 2006, 5: 581–589
Goldman E R, Anderson G P, Tran P T, et al. Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays. Anal Chem, 2002, 74: 841–847
Wang Y A, Li J J, Chen H, et al. Stabilization of inorganic nanocrystals by organic dendrons. J Am Chem Soc, 2002, 124: 2293–2298
Chan W C W, Prendergast T L, Jain M, et al. One-step conjugation of biomolecules to luminescent nanocrystals. Proc SPIE, 2000, 3924: 2–9
Pathak S, Choi S K, Arnheim N, et al. Hydroxylated quantum dots as luminescent probes for in situ hybridization. J Am Chem Soc, 2001, 123: 4103–4104
Mirkin C A, Letsinger R L, Mucic R C, et al. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature, 1996, 382: 607–609
Willard D M, Carillo L L, Jung J, et al. CdSe-ZnS quantum dots as resonance energy transfer donors in a model protein-protein binding assay. Nano Let, 2001, 1: 469–474
Goldman E R, Balighian E D, Mattoussi H, et al. Avidin: a natural bridge for quantum dot-antibody conjugates. J Am Chem Soc, 2002, 124: 6378–6382
Rosenthal S J, Tomlinson I, Adkins E M, et al. Targeting cell surface receptors with ligand-conjugated nanocrystals. J Am Chem Soc, 2002, 124: 4586–4594
Dennis A M, Bao G. Quantum dot-fluorescent protein pairs as novel fluorescence resonance energy transfer probes. Nano Lett, 2008, 8: 1439–1445
Sapsford K E, Pons T, Medintz I L, et al. Biosensing with luminescent semiconductor quantum dots. Sensors-Basel, 2006, 6: 925–953
Qu L, Peng X. Control of photoluminescence properties of CdSe nanocrystals in growth. J Am Chem Soc, 2002, 124: 2049–2055
Striolo A, Ward J, Prausnitz J M, et al. Molecular weight, osmotic second virial coefficient, and extinction coefficient of colloidal CdSe nanocrystals. J Phys Chem B, 2002, 106: 5500–5505
Chan W C W, Maxwell D J, Gao X H, et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotech, 2002, 13: 40–46
Lakowicz J R. Principles of fluorescence spectroscopy. New York: Springer, 2006
Clapp A R, Medintz I L, Mattoussi H. Forster resonance energy transfer investigations using quantum-dot fluorophores. Chem Phys Chem, 2006, 7: 47–57
Sapsford K E, Pons T, Medintz I L, et al. Kinetics of metal-affinity driven self-assembly between proteins or peptides and CdSe-ZnS quantum dots. J Phys Chem C, 2007, 111: 11528–11538
Susumu K, Uyeda H T, Medintz I L, et al. Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands. J Am Chem Soc, 2007, 129: 13987–13996
Shaner N C, Campbell R E, Steinbach P A, et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol, 2004, 22: 1567–1572
Shaner N C, Steinbach P A, Tsien R Y. A guide to choosing fluorescent proteins. Nat Methods, 2005, 2: 905–909
Busa W B, Nuccitelli R. Metabolic regulation via intracellular pH. Am J Physiol, 1984, 246: R409–R438
Tyagi S, Kramer F R. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol, 1996, 14: 303–308
Tyagi S, Bratu D P, Kramer F R. Multicolor molecular beacons for allele discrimination. Nat Biotechnol, 1998, 16: 49–53
Li J J, Geyer R, Tan W. Using molecular beacons as a sensitive fluorescence assay for enzymatic cleavage of single-stranded DNA. Nucleic Acids Res, 2000, 28: E52
Dirks R W, Molenaar C, Tanke H J. Methods for visualizing RNA processing and transport pathways in living cells. Histochem Cell Biol, 2001, 115: 3–11
Molenaar C, Marras S A, Slats J C, et al. Linear 2′ O-Methyl RNA probes for the visualization of RNA in living cells. Nucleic Acids Res, 2001, 29: E89–89
Sokol D L, Zhang X, Lu P, et al. Real time detection of DNA.RNA hybridization in living cells. Proc Natl Acad Sci USA, 1998, 95: 11538–11543
Vet J A, Majithia A R, Marras S A, et al. Multiplex detection of four pathogenic retroviruses using molecular beacons. Proc Natl Acad Sci USA, 1999, 96: 6394–6399
Kostrikis L G, Tyagi S, Mhlanga M M, et al. Spectral genotyping of human alleles. Science, 1998, 279: 1228–1229
Piatek A S, Tyagi S, Pol A C, et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotech, 1998, 16: 359–363
Bratu D P, Cha B J, Mhlanga M M, et al. Visualizing the distribution and transport of mRNAs in living cells. Proc Natl Acad Sci USA, 2003, 100: 13308–13313
Tsourkas A, Behlke M A, Xu Y, et al. Spectroscopic features of dual fluorescence/luminescence resonance energy-transfer molecular beacons. Anal Chem, 2003, 75: 3697–3703
Santangelo P J, Nix B, Tsourkas A, et al. Dual FRET molecular beacons for mRNA detection in living cells. Nucleic Acids Res, 2004, 32: e57
Nitin N, Santangelo P J, Kim G, et al. Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. Nucleic Acids Res, 2004, 32: e58
Tyagi S, Alsmadi O. Imaging native beta-actin mRNA in motile fibroblasts. Biophys J, 2004, 87: 4153–4162
Peng X H, Cao Z H, Xia J T, et al. Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research. Cancer Res, 2005, 65: 1909–1917
Medley C D, Drake T J, Tomasini J M, et al. Simultaneous monitoring of the expression of multiple genes inside of single breast carcinoma cells. Anal Chem, 2005, 77: 4713–4718
Tsourkas A, Behlke M A, Bao G. Structure-function relationships of shared-stem and conventional molecular beacons. Nucleic Acids Res, 2002, 30: 4208–4215
King F W, Liszewski W, Ritner C, et al. High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons. Stem Cells Dev, 2011, 20: 475–484
Chen A K, Rhee W J, Bao G, et al. Delivery of molecular beacons for live-cell imaging and analysis of RNA. Methods Mol Biol, 2011, 714: 159–174
Giles R V, Ruddell C J, Spiller D G, et al. Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells. Nucleic Acids Res, 1995, 23: 954–961
Barry M A, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys, 1993, 300: 440–450
Giles R V, Spiller D G, Grzybowski J, et al. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells. Nucleic Acids Res, 1998, 26: 1567–1575
Walev I, Bhakdi S C, Hofmann F, et al. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci USA, 2001, 98: 3185–3190
Wadia J S, Dowdy S F. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev, 2005, 57: 579–596
Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev, 2005, 57: 559–577
Nitin N, Bao G. NLS peptide conjugated molecular beacons for visualizing nuclear RNA in living cells. Bioconj Chem, 2008, 19: 2205–2211
Czernin J, Allen-Auerbach M, Schelbert H. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nuclear Med, 2007, 48: 78S
Judenhofer M S, Wehrl H F, Newport D F, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med, 2008, 14: 459–465
Higuchi T, Anton M, Dumler K, et al. Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart. J Nucl Med, 2009, 50: 1088–1094
Xu H, Regino C A, Koyama Y, et al. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug Chem, 2007, 18: 1474–1482
Koyama Y, Talanov V S, Bernardo M, et al. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging, 2007, 25: 866–871
Lee S K, Chen X. Dual-modality probes for in vivo molecular imaging. Mol Imaging, 2009, 8: 87–100
Carmeliet P. Angiogenesis in health and disease. Nat Med, 2003, 9: 653–660
Lee H Y, Li Z, Chen K, et al. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J Nucl Med, 2008, 49: 1371–1379
Xie J, Huang J, Li X, et al. Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem, 2009, 16: 1278–1294
Shokeen M, Fettig N M, Rossin R. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles. Q J Nucl Med Mol Imaging, 2008, 52: 267–277
Wang Y X, Hussain S M, Krestin G P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol, 2001, 11: 2319–2331
Bjornerud A, Wendland M F, Johansson L, et al. Use of intravascular contrast agents in MRI. Acad Radiol, 1998, 5: S223–225
Weissleder R, Bogdanov A, Neuwelt E A, et al. Long-circulating iron-oxides for MR imaging. Adv Drug Deliv Rev, 1995, 16: 321–334
Jun Y W, Huh Y M, Choi J S, et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc, 2005, 127: 5732–5733
Xu C J, Sun S H. Monodisperse magnetic nanoparticles for biomedical applications. Polymer Int, 2007, 56: 821–826
Lee J H, Huh Y M, Jun Y W, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med, 2007, 13: 95–99
Nitin N, LaConte L E, Zurkiya O, et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J Biol Inorg Chem, 2004, 9: 706–712
Yu W W, Chang E, Sayes C M, et al. Aqueous dispersion of monodisperse magnetic iron oxide nanocrystals through phase transfer. Nanotechnology, 2006, 17: 4483–4487
Gossuin Y, Gillis P, Hocq A, et al. Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2009, 1: 299–310
Nahrendorf M, Jaffer F A, Kelly K A, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation, 2006, 114: 1504–1511
Montet X, Montet-Abou K, Reynolds F, et al. Nanoparticle imaging of integrins on tumor cells. Neoplasia, 2006, 8: 214–222
Winter P M, Morawski A M, Caruthers S D, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation, 2003, 108: 2270–2274
Glaus C, Rossin R, Welch M J, et al. In vivo evaluation of 64Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug Chem, 2010, 21: 715–722
Gillis P, Koenig S H. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn Reson Med, 1987, 5: 323–345
Gillis P, Moiny F, Brooks R A. On T2-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med, 2002, 47: 257–263
Brooks R A, Moiny F, Gillis P. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med, 2001, 45: 1014–1020
Koenig S H, Kellar K E. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med, 1995, 34: 227–233
Jun Y W, Seo J W, Cheon A. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc Chem Res, 2008, 41: 179–189
Tromsdorf U I, Bigall N C, Kaul M G, et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Letters, 2007, 7: 2422–2427
Yu W W, Falkner J C, Yavuz C T, et al. Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts. Chem Commun, 2004, 2306–2307
Xie J, Peng S, Brower N, et al. One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications. Pure Appl Chem, 2006, 78: 1003–1014
Li J J, Wang Y A, Guo W Z, et al. Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction. J Am Chem Soc, 2003, 125: 12567–12575
Xie J, Xu C, Kohler N, et al. Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater, 2007, 19: 3163–3166
Torchilin V P, Trubetskoy V S. Which polymers can make nanoparticulate drug carriers long-circulating. Adv Drug Deliv Rev, 1995, 16: 141–155
Tong S, Hou S J, Zheng Z L, et al. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett, 2010, 10: 4607–4613
Josephson L, Perez J M, Weissleder R. Magnetic nanosensors for the detection of oligonucleotide sequences. Angew Chem Int Edit, 2001, 40: 3204–3206
Hazarika P, Ceyhan B, Niemeyer C M. Reversible switching of DNA-gold nanoparticle aggregation. Angew Chem Int Edit, 2004, 43: 6469–6471
Montet X, Funovics M, Montet-Abou K, et al. Multivalent effects of RGD peptides obtained by nanoparticle display. J Med Chem, 2006, 49: 6087–6093
Pellegrino T, Manna L, Kudera S, et al. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: A general route to water soluble nanocrystals. Nano Lett, 2004, 4: 703–707
Stolnik S, Illum L, Davis S S. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev, 1995, 16: 195–214
Liu Z, Davis C, Cai W, et al. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA, 2008, 105: 1410–1415
Glaus C, Rossin R, Welch M J, et al. In vivo evaluation of 64Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Bioconjug Chem, 2010, 21: 715–722
Torchilin V P. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev, 2002, 54: 235–252
Johnsson M, Hansson P, Edwards K. Spherical micelles and other self-assembled structures in dilute aqueous mixtures of poly(ethylene glycol) lipids. J Phys Chem B, 2001, 105: 8420–8430
Turro N J, Yekta A. Luminescent probes for detergent solutions—simple procedure for determination of mean aggregation number of micelles. J Am Chem Soc, 1978, 100: 5951–5952
Tong S, Hou S, Ren B, et al. Self-assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange. Nano Lett, 2011, 11: 3720–3726
Zhu M T, Wang B, Wang Y, et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. Toxicol Lett, 2011, 203: 162–171
Hyafil F, Cornily J C, Feig J E, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med, 2007, 13: 636–641
Haller C, Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol, 2004, 39: 149–154
Kong W H, Lee W J, Cui Z Y, et al. Nanoparticulate carrier containing water-insoluble iodinated oil as a multifunctional contrast agent for computed tomography imaging. Biomaterials, 2007, 28: 5555–5561
Badea C T, Athreya K K, Espinosa G, et al. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS ONE, 2012, 7: e34496
Hoglund P, Leander P, Hustvedt S O, et al. Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT. Acad Radiol, 1998, 5: S47–S48
Kim D, Park S, Lee J H, et al. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging. J Am Chem Soc, 2007, 129: 7661–7665
Wang H, Zheng L F, Guo R, et al. Dendrimer-entrapped gold nanoparticles as potential CT contrast agents for blood pool imaging. Nanoscale Res Lett, 2012, 7: 190–197
Liu H, Wang H, Guo R, et al. Size-controlled synthesis of dendrimer-stabilized silver nanoparticles for X-ray computed tomography imaging applications. Polym Chem-UK, 2010, 1: 1677–1683
Rabin O, Perez J M, Grimm J, et al. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater, 2006, 5: 118–122
Ai K L, Liu Y L, Liu J H, et al. Large-scale synthesis of Bi2S3 nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv Mater, 2011, 23: 4886–4891
Kinsella J M, Jimenez R E, Karmali P P, et al. X-Ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Edit, 2011, 50: 12308–12311
Oh M H, Lee N, Kim H, et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc, 2011, 133: 5508–5515
Lee N, Cho H R, Oh M H, et al. Multifunctional Fe3O4/TaOx core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. J Am Chem Soc, 2012, 134: 10309–10312
Jain R K. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev, 2001, 46: 149–168
von Maltzahn G, Park J H, Lin K Y, et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater, 2011, 10: 545–552
Weissleder R, Stark D D, Engelstad B L, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol, 1989, 152: 167–173
Namiki Y, Namiki T, Yoshida H, et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol, 2009, 4: 598–606
Fortin J P, Wilhelm C, Servais J, et al. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc, 2007, 129: 2628–2635
Alexiou C, Arnold W, Klein R J, et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res, 2000, 60: 6641–6648
Park J H, von Maltzahn G, Ruoslahti E, et al. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Edit, 2008, 47: 7284–7288
Jain T K, Richey J, Strand M, et al. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials, 2008, 29: 4012–4021
Guthi J S, Yang S G, Huang G, et al. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol Pharm, 2010, 7: 32–40
Liong M, Lu J, Kovochich M, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano, 2008, 2: 889–896
Dilnawaz F, Singh A, Mohanty C, et al. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials, 2010, 31: 3694–3706
Santra S, Kaittanis C, Grimm J, et al. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small, 2009, 5: 1862–1868
Kim J, Kim H S, Lee N, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl, 2008, 47: 8438–8441
Nobuto H, Sugita T, Kubo T, et al. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int J Cancer, 2004, 109: 627–635
Medarova Z, Pham W, Farrar C, et al. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med, 2007, 13: 372–377
Lee J H, Lee K, Moon S H, et al. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl, 2009, 48: 4174–4179
Shin J M, Anisur R M, Ko M K, et al. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Edit, 2009, 48: 321–324
Choi J S, Lee J H, Shin T H, et al. Self-confirming “AND” logic nanoparticles for fault-free MRI. J Am Chem Soc, 2010, 132: 11015–11017
Bartlett D W, Su H, Hildebrandt I J, et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA, 2007, 104: 15549–15554
Chen W, Xu N, Xu L, et al. Multifunctional magnetoplasmonic nanoparticle assemblies for cancer therapy and diagnostics (theranostics). Macromol Rapid Commun, 2010, 31: 228–236
Hu J, Qian Y, Wang X, et al. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging. Langmuir, 2012, 28: 2073–2082
Kopelman R, Koo Y E L, Philbert M, et al. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J Magn Magn Mater, 2005, 293: 404–410
Zheng J, Allen C, Serra S, et al. Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology. Contrast Media Mol Imag, 2010, 5: 147–154
Barth B M, Sharma R, Altinoglu E I, et al. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano, 2010, 4: 1279–1287
Guo R, Zhang L, Qian H, et al. Multifunctional nanocarriers for cell imaging, drug delivery, and near-IR photothermal therapy. Langmuir, 2010, 26: 5428–5434
Lin X, Xie J, Niu G, et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett, 2011, 11: 814–819
Jain T K, Morales M A, Sahoo S K, et al. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm, 2005, 2: 194–205
Dames P, Gleich B, Flemmer A, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol, 2007, 2: 495–499
Wood A J, Lo T W, Zeitler B, et al. Targeted genome editing across species using ZFNs and TALENs. Science, 2011, 333: 307
Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 2009, 326: 1509–1512
Porteus M H, Baltimore D. Chimeric nucleases stimulate gene targeting in human cells. Science, 2003, 300: 763
Rouet P, Smih F, Jasin M. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci USA, 1994, 91: 6064–6068
Bitinaite J, Wah D A, Aggarwal A K, et al. Fok I dimerization is required for DNA cleavage. Proc Natl Acad Sci USA, 1998, 95: 10570–10575
Smith J, Bibikova M, Whitby F G, et al. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res, 2000, 28: 3361–3369
Moscou M J, Bogdanove A J. A simple cipher governs DNA recognition by TAL effectors. Science, 2009, 326: 1501
Cradick T J, Ambrosini G, Iseli C, et al. ZFN-site searches genomes for zinc finger nuclease target sites and off-target sites. BMC Bioinformatics, 2011, 12: 152
Miller J C, Holmes M C, Wang J, et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol, 2007, 25: 778–785
Ramirez C L, Certo M T, Mussolino C, et al. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res, 2012, 40: 5560–5568
Perez E E, Wang J, Miller J C, et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol, 2008, 26: 808–816
Platt O S, Brambilla D J, Rosse W F, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med, 1994, 330: 1639–1644
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Tong, S., Cradick, T.J., Ma, Y. et al. Engineering imaging probes and molecular machines for nanomedicine. Sci. China Life Sci. 55, 843–861 (2012). https://doi.org/10.1007/s11427-012-4380-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-012-4380-1